Advanced Search

    column
    Uncommon/Rare Mutations in Non-Small Cell Lung Cancer: Consensus and Contention
    WU Yi-long, LU Shun, CHENG Ying, ZHOU Qing, TU Hai-yan, ZHOU Qing-hua, WANG LU-hua, ZHANG Li（Guangzhou）, ZHOU Jian-ying, HUANG Cheng, CHEN Ming, HU Cheng-ping, CHUAI Shao-kun, WANG Xiao-nan, LIU Xiao-qing, LIU Ji-wei, ZHOU Peng-hui, CHEN Wei-zhi, YAN Ling-hua, LIU Yun-peng, LIU An-wen, ZHANG Xu-chao, LI Hui, CHEN Rong-rong, LIN Dong-mei, XIE Cong-ying, ZHU Zheng-fei, LIANG Hui-ying, SONG Yong, DONG Xiao-rong, ZHAO Ming-fang, QIAO Gui-bin, CUI Jiu-wei, LI Zi-ming, WANG Zhi-jie, CHEN Xiao-yuan, YANG Nong, LIN Gen, TIAN Pan-wen, FAN Yun, SONG Qi-bin, CHEN Yuan, DUAN Jian-chun, WANG Jia-lei, ZHU Bo, WANG Bu-hai, ZHAO Jun, YU Qi-tao, WANG Li-feng, ZHANG Hai-bo, HU Jie, MA Rui, ZHANG Tong-mei, LIN Jie, CHU Qian, REN Sheng-xiang, YAO Yu, WU Lin, WANG Hui-juan, WU Fang, ZHONG Wen-zhao, HU Yi, CHEN Ke-neng, ZHAO Jian, ZHANG Li（Beijing）, YANG Fan, WANG Qun, YUE Dong-sheng, ZHOU Jian-ya, SHEN Peng, ZHANG Jia-tao, YAN Xiao-long, HUANG Mei-juan, FENG Wei-neng, LI Li, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials (GACT)/ Chinese Thoracic Oncology Group(CTONG)
    2023, 23(3): 129-139. DOI: 10.12019/j.issn.1671-5144.2023.03.001
    Abstract PDF
    An Interview in 2023 Chinese Lung Cancer Summit Forum
    LI Rui-na, ZHANG Yuan-dong, ZHANG Hua, ZHOU Qing
    2023, 23(3): 140-148. DOI: 10.12019/j.issn.1671-5144.2023.03.002
    Abstract PDF
    Prognostic Value of ROS1 in Patients With Renal Clear Cell Carcinoma
    HE Ning, LI Le-le, HU Ta-la, XU Rui-feng, GAO Wu-ni-ri, LAI Can, YU Lei, MENG Yan
    2023, 23(3): 149-155. DOI: 10.12019/j.issn.1671-5144.2023.03.003
    Abstract PDF
    Construction and Evaluation of Prognostic Model With Cuproptosis-Related lncRNA in Hepatocellular Carcinoma
    MA Jian-jun, XIONG Yong-qiang, WANG Bo, LIU Qi, LI Ren, ZHANG Shu
    2023, 23(3): 156-168. DOI: 10.12019/j.issn.1671-5144.2023.03.004
    Abstract PDF
    Incidence and Mortality of Cancer in Elderly Population in China
    MENG Fan-ying, YU Lei, MA Xiao-tong, SUN Hui-xin
    2023, 23(3): 169-173. DOI: 10.12019/j.issn.1671-5144.2023.03.005
    Abstract PDF
    Analysis of the Status and Influencing Factors of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer Patients
    CHEN Xiu-mei, CHEN Si-juan, GAN Bin, QIU Jie, CUI Hong, YAN Hong-hong
    2023, 23(3): 174-180. DOI: 10.12019/j.issn.1671-5144.2023.03.006
    Abstract PDF
    Proceedings in the Study of the Role of Intrinsic Innate Immunity of Epithelial Cells in EBV-Associated Tumors
    CHEN Ji, ZHANG Xu-chao
    2023, 23(3): 181-188. DOI: 10.12019/j.issn.1671-5144.2023.03.007
    Abstract PDF
    The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy
    LI Yang-si, CEN En-ni, WANG Zhen, TU Hai-yan
    2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
    Abstract PDF